Citadel Investment Advisory’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
CAM
WF
RG
LWCFA
Citadel Investment Advisory's IDXX Position: Q2 2026 in Review
Citadel Investment Advisory reduced its Idexx Laboratories (IDXX) stake by 0.14% in Q2 2026, selling an estimated $2.8K and leaving 3,486 shares worth $1.83M. The position accounts for 0.83% of the portfolio, ranked #26.
Citadel Investment Advisory first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.6M in Q4 2021. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Citadel Investment Advisory held 3,486 shares of Idexx Laboratories worth $1.83M as of Q2 2026.
- Citadel Investment Advisory sold 5 Idexx Laboratories shares in Q2 2026, an estimated $2.8K.
- Idexx Laboratories made up 0.83% of Citadel Investment Advisory's portfolio in Q2 2026, its #26 holding.
- Citadel Investment Advisory first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
- Citadel Investment Advisory's Idexx Laboratories position peaked at $2.6M in Q4 2021.
- 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Citadel Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.